Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07302789Not ApplicableCompleted

Clinical Effects of Two Oral Bioactive Collagen Peptides On Skin Properties and Aging Hallmarks

Role: lead

NCT07255560Not ApplicableCompleted

DMAE Oleate for Facial Skin Firmness and Fine Lines in Healthy Adults

Role: lead

NCT05722158Not ApplicableCompleted

Bioavailability of Different Collagen-based Treatments After Oral Intake

Role: lead

NCT07300813Not ApplicableActive Not Recruiting

Olistic_2025 for Hair Loss, Hair Growth, and Skin Improvement

Role: lead

NCT06225349Not ApplicableCompleted

Clinical Evaluation of the Magnesium Absorption Kinetics in Human Plasma Upon Oral Intake of Magnesium-based Products

Role: lead

NCT06059534Not ApplicableCompleted

Evaluation of the Effects of DracoBelle Nu in Skin Health After Oral Intake

Role: lead

All 6 trials loaded